Expression of p53, epidermal growth factor receptor, Ki-67 and O6-methylguanine-DNA methyltransferase in human gliomas

Role of p53 gene polymorphism and bladder cancer predisposition in northern India

(2017) Priyanka Srivastava et al.   Cancer Biomarkers

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study

(2011) Andreas H Habberstad et al.   Diagnostic Pathology

The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations

(2010) Andreas Von Deimling et al.   BRAIN PATHOLOGY

P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

(2010) Georgia Levidou et al.   JOURNAL OF NEURO-ONCOLOGY

Molecular markers in gliomas: impact for the clinician

(2010) Silvia Hofer et al.   Targeted Oncology

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor

(2008) Minoru Kogiku et al.   JOURNAL OF CLINICAL NEUROSCIENCE